Mapping fat-cell sizes around the coronary arteries to trace inflammation
Official title: Direct Measurement of Pericoronary Adipocyte Size Gradient as a Parameter of Immunometabolic Changes of Perivascular Adipose Tissue
Run by Institute for Clinical and Experimental Medicine · NCT07360925 · Data updated 2026-11-12
This project will test whether differences in fat-cell size next to the coronary arteries can show how inflammation spreads in people having a heart transplant for advanced heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 90 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Institute for Clinical and Experimental Medicine Government |
| Locations | 1 site (Prague) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | July 1, 2028 |
| Study ends | July 1, 2029 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT07360925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30–90 with a diagnosis of dilated or ischemic cardiomyopathy who are undergoing heart transplantation at IKEM and can give informed consent.
✕Probably not a fit
Patients with combined dilated and ischemic cardiomyopathy, arrhythmogenic cardiomyopathy, congenital heart defects, those not undergoing transplantation at IKEM, or those unable to consent are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect explanted hearts during heart transplantation at IKEM from patients with ischemic or dilated cardiomyopathy. Pericoronary adipose tissue samples close to and farther from the arterial lumen will be analyzed for adipocyte size, immunometabolic markers, and macrophage changes to create spatial gradients. Clinical data including age, BMI, comorbidities, medications and prior LVAD use will be recorded to relate tissue findings to patient context and altered coronary flow. Results will compare patients with advanced atherosclerosis to those with less atherosclerotic disease to determine patterns of local inflammation propagation.
Why it matters
Potential benefit: If successful, this could reveal how local fat inflammation contributes to coronary artery disease and point to new targets for prevention or treatment.
How similar studies have gone: Previous research has linked pericoronary adipose inflammation to coronary disease, but direct mapping of adipocyte-size gradients in explanted human hearts is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 30-90 years * Diagnosis of dilatational or ischemic cardiomyopathy * Patients undergoing heart transplantation in IKEM Exclusion Criteria: * Known combined diagnosis of dilatational and ischemic cardiomyopathy * Arrhythmogenic cardiomyopathy * Congenital heart defects * Non-eligibility due to the absence of informed consent
Where it's running
-
Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine,
Prague, Czechia Recruiting
Study contacts
- Study coordinator: Ivana K Lesna, MD, PhD., assoc. prof.
- Email: ivana.kralova.lesna@ikem.cz
- Phone: 00420236055445
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiac rehabilitation cohort at Medicine Campus Davos to explore recovery
This project will follow adults coming to Hochgebirgsklinik Davos for cardiac rehabilitation to see how their heart health and recovery progress over time.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Creating an electronic registry for patients with advanced heart failure and heart transplantation
This study is trying to create an electronic record system to track patients with advanced heart failure and heart transplants to better understand their health and hospital visits.
-
Preventive catheter ablation for heart failure patients with ventricular arrhythmias
This study is testing if a heart procedure called catheter ablation can help heart failure patients with irregular heartbeats live longer and feel better compared to standard treatment before they get a heart transplant.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
New imaging protocol for heart conditions
This study is testing a new imaging method for heart conditions to see if it can improve diagnosis and treatment for over 10,000 patients with heart issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.